Most Popular Stories
- UnitedHealth reveals details of option back-dating settlement
- DOD, VA move to SOA architecture to build interoperable systems
- Social Security wants EMR access for disability determination
- Another attempt to halt Horizon BCBS of NJ's switch to for-profit
- Study: EMRs can cut paid malpractice settlements
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- AHA survey: Negative profit margins for hospitals
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Healthcare on track to set record for mass layoffs
- DOD, VA move to SOA architecture to build interoperable systems
- Study: EMRs can cut paid malpractice settlements
- Signs of trouble in the Motor City
Poll
Featured Jobs
-
Arizona Intensive Care RN
StaffPointe, LLC - north , AZ -
Florida Med Peds
StaffPointe, LLC - Panhandle , FL -
Arkansas General Surgeon
StaffPointe, LLC - east central , AR -
Arizona Nurse Practitioner
StaffPointe, LLC - southwest , AZ -
California Radialogy Tech Cath Lab
StaffPointe, LLC - Modesto , CA
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
NH bans prescription data collection by pharmas
New Hampshire became the first state to pass a law prohibiting pharmaceutical companies from collecting data on physician prescribing habits. The state's senate voted unanimously to support legislation sponsored by Rep. Cindy Rosenwald. The house has already passed the provision. New Hampshire Gov. John Lynch (D) must now sign the legislation for it to become law. The AARP and the New Hampshire Medical Society have both come out in support of the legislation.
Why is this important? New Hampshire's action could set the stage for similar laws across the country, something drug industry critics have argued could help put the doctor-pharma relationship back in its proper context. A spokesman for IMS Health, which runs a multi-billion dollar business built on supplying that data, stated, "We think making the information available has public good." And private good too, no doubt.
- read this article from the New Hampshire Union Leader
Related Stories
- AstraZeneca asks judge to nullify $215M drug-price lawsuit
- Pharma gift disclosure law wins Eli Lilly support
- College group urges ban on drug, devicemaker freebies
- Louisiana MDs win legal battle over patient record disclosure
- Who will pay for DTC pharma ad oversight?
- FDA rules on off-label article distribution issued
- Biotechs eager for FDA approval of biogeneric drugs
- DC passes pharma rep licensing rule
- Statin drug probably not going OTC
- Study: Med school pharma limits affect attitudes
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





